1 |
Muñoz-Delgado L, Macías-García D, Periñán MT, Jesús S, Adarmes-Gómez AD, Bonilla Toribio M, Buiza Rueda D, Jiménez-Jaraba MDV, Benítez Zamora B, Díaz Belloso R, García-Díaz S, Martín-Bórnez M, Pineda Sánchez R, Carrillo F, Gómez-Garre P, Mir P. Peripheral inflammatory immune response differs among sporadic and familial Parkinson's disease. NPJ Parkinsons Dis 2023;9:12. [PMID: 36720879 DOI: 10.1038/s41531-023-00457-5] [Reference Citation Analysis]
|
2 |
Szelechowski M, Texier B, Prime M, Atamena D, Belenguer P. Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson’s disease. Neural Regen Res 2023;18:293. [DOI: 10.4103/1673-5374.346487] [Reference Citation Analysis]
|
3 |
Abu Manneh R, Chairta PP, Mitsi E, Loizidou MA, Georgiou AN, Christou YP, Pantzaris M, Zamba-Papanicolaou E, Hadjisavvas A. Genetic Study of Early Onset Parkinson's Disease in Cyprus. Int J Mol Sci 2022;23. [PMID: 36499697 DOI: 10.3390/ijms232315369] [Reference Citation Analysis]
|
4 |
Zedde M, Pascarella R, Cavallieri F, Pezzella FR, Grisanti S, Di Fonzo A, Valzania F. Anderson-Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease? Biomedicines 2022;10. [PMID: 36551888 DOI: 10.3390/biomedicines10123132] [Reference Citation Analysis]
|
5 |
Dulski J, Uitti RJ, Ross OA, Wszolek ZK. Genetic architecture of Parkinson’s disease subtypes – Review of the literature. Front Aging Neurosci 2022;14:1023574. [DOI: 10.3389/fnagi.2022.1023574] [Reference Citation Analysis]
|